title: [Toxic epidermal necrolysis associated with abacavir].
authors.forename: Milagro
authors.initials: M
authors.lastname: Montero
authors.forename: Lidia
authors.initials: L
authors.lastname: García-Gibert
authors.forename: Ana María
authors.initials: AM
authors.lastname: Giménez-Arnau
authors.forename: Hernando
authors.initials: H
authors.lastname: Knobel
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D016049:Didanosine / Q000627:therapeutic use; D015224:Dideoxynucleosides / Q000009:adverse effects* / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy; D039682:HIV-Associated Lipodystrophy Syndrome / Q000188:drug therapy; D006801:Humans; D008297:Male; D019829:Nevirapine / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D018119:Stavudine / Q000009:adverse effects / Q000627:therapeutic use; D013262:Stevens-Johnson Syndrome / Q000209:etiology*; D000099227:Abacavir
chemical_list: D019380:Anti-HIV Agents; D016049:Didanosine; D015224:Dideoxynucleosides; D019829:Nevirapine; D018894:Reverse Transcriptase Inhibitors; D018119:Stavudine; D000099227:Abacavir